Fast-growing French biotechnology company bioMérieux has outgrown its space at the University City Science Center and will relocate into 32,000 square feet at a building under development at the Philadelphia Navy Yard. 

It’s the first lease signed for the new building at 1201 Normandy Place, a project scheduled to open in June. BioMérieux plans to move there in early 2024. The building is being developed by Ensemble Real Estate Investments and Mosaic Development Partners in partnership with Oxford Properties. 

BioMérieux bought Philadelphia-based Invisible Sentinel in 2019 for $75 million. The new site will house Invisible Sentinel, a provider of DNA detection tools to protect against impurities in food, beer, wine and medical cannabis production.

*Article courtesy of Philadelphia Business Journal

For more information about Philadelphia medical space for sale or lease or about any other Philadelphia properties for sale or lease, please contact WCRE at 215-799-6900.

Wolf Commercial Real Estate, a full-service CORFAC International brokerage and advisory firm, is a premier  medical commercial real estate broker that provides a full range of commercial real estate listings and services, property management services, and marketing commercial offices, medical properties, industrial properties, land properties, retail buildings and other commercial properties for buyers, tenants, investors, and sellers.

Please visit our website for a full listing of Philadelphia commercial properties for sale or lease, www.wolfcre.com.